The art and agitprop of Ebola
This morning Businessweek used this cover while running an excellent article on the bureaucratic delays on developing an effective Ebola drug:
Credit: Bloomberg Businessweek
http://crofsblogs.typepad.com/h5n1/2014/09/the-art-and-agitprop-of-ebola.html
No comments:
Post a Comment